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ABSTRACT
IDENTIFICATION OF VIRULENCE AND ANTIBIOTIC RESISTANT GENE
IN LABORATORY STRAINS Streptococcus agalactiae
Streptococcus agalactiae or Group B Streptococcus (GBS) is a causative agent for
serious infection and neonatal sepsis that lead to neonatal morbidity and mortality.
Previous study proved that the pathogenesis of Streptococcus agalactiae infection is
complex and the severity can be predicted by the identification of the virulence factors
encoded among others by the cps gene cluster coding of the Streptococcus agalactiae
capsule. However, there is a lack of study done on the laboratory strains Streptococcus
agalactiae. Study done stated that the laboratory strains are unable to fully represent
microorganism that growth in the 'real-world' environment. This study is done to
identify the virulence genes and antibiotic resistance genes in Streptococcus agalactiae
isolates from laboratory reference strains. The laboratory strains Streptococcus
agalactiae are sub-cultured into two different time frames in order to observe for any
genetic drift or variations. The detection of the virulence gene 1mb, cylE, bca, scpB, and
rib gene and antibiotic resistant genes ermB gene and tetO gene are done by using
SYBR Green real-time PCR. All the samples from both short term and long term time
frame were analyzed for the presence of the virulence and antibiotic resistant genes. The
outcomes of the analysis indicate there were no genetic drifts or variants for 1mb, cylE
bca, scpB gene even after a series of passage. The rib gene is undetermined for genetic
variations or drift since not all the sample expressed the gene. The ermB gene and tetO
gene analysis were undetermined since the results of the analysis are not specific. The
comparison between clinical sample and laboratory strains show that the laboratory
strains expressed the same virulence genes as the clinical samples. This study suggested
that the used of real-time PCR are specific and sensitive methods that could be used to
detect the virulence gene of Streptococcus agalactiae.
Keywords: Streptococcus agalactiae, virulence genes, antibiotic resistant genes, real-
time PCR.
CHAPTER 1
INTRODUCTION
1.1 Study background
Streptococcus agalactiae or Group B Streptococcus (GBS) is a causative agent
for serious infection and neonatal sepsis that lead to neonatal morbidity and mortality,
Streptococcus agalactiae also act as an opportunistic agents for infection in pregnant
women, adult especially elderly with underlying medical condition (Dutra et aI, 2014).
Infection in neonate is divided into two stages; early-onset and late-onset. Early onset
infection occurs within the first week of life while late-onset diseases occur between 1
week and 3 month of age (Eskandarian et al., n.d.). Center of Diseases Control (CDC)
in USA are recommending for all the pregnant women at 35 - 37 weeks of gestation to
be screen for Streptococcus agalactiae colonization to reduce the risk of neonate
infection of Streptococcus agalactiae. Antimicrobial Prophylaxis that are offered to
women with positive colonization of Streptococcus agalactiae will lead to more than
70% reduction in early onset GBS infection in neonates (Hannoun et al., 2009).
There are ten serotype of Streptococcus agalactiae which are la, Ib, II, III, IV,
V, VI, VII, VIII and IX according to their unique polysaccharide capsule (Laczeski,
Pegels, Oviedo, Quiroga, & Vergara, 2014) . However, serotypes of Streptococcus
agalactiae are found to be varied according to the time and also geographical factor. In
the USA and Europe, the predominate Streptococcus agalactiae serotype are la, II, III
and V, while serotype Ib and III are found to be the predominate serotype in Japan.
Previous study done in Malaysia detennine that serotype la and VI are the predominate
Streptococcus agalactiae serotype among pregnant women (Eskandarian et al., n.d.).
